Iran, Islamic Republic of vs South Africa: Hypertension effective treatment coverage (controlled hypertension)
Iran, Islamic Republic of
24.1%
in 2019
South Africa
23.6%
in 2019
Iran, Islamic Republic of rank
56th
South Africa rank
59th
Hypertension effective treatment coverage (controlled hypertension) over time
- Iran, Islamic Republic of
- South Africa
How they compare
Iran, Islamic Republic of currently reports 24.1% against 23.6% in South Africa, a difference of 0.5%.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Iran, Islamic Republic of ahead.
Iran, Islamic Republic of ranks 56th and South Africa ranks 59th of 193 countries.
Across the 3 decades both report, Iran, Islamic Republic of averaged higher in 1 and South Africa in 2.
Head to head by decade
| Decade | Iran, Islamic Republic of | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 5.5% | 5.6% | 0.1% | South Africa |
| 2000s | 10.5% | 11.3% | 0.9% | South Africa |
| 2010s | 21.1% | 19.6% | 1.5% | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Iran, Islamic Republic of or South Africa?
- Iran, Islamic Republic of, at 24.1% against 23.6% in South Africa as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Iran, Islamic Republic of and South Africa?
- 0.5%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and South Africa?
- 30 years are reported by both, from 1990 to 2019.
- How do Iran, Islamic Republic of and South Africa rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Iran, Islamic Republic of ranks 56th and South Africa ranks 59th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.